Up next

Autoplay

Dr. Ai on the Efficacy of Brentuximab Vedotin in Patients With Advanced Cutaneous T-Cell Lymphoma

5 Views • 08/09/23
Share
Embed
administrator
administrator
Subscribers
0

Weiyun Z. Ai, MD, PhD, assistant clinical professor, Department of Medicine, University of California San Francisco, discusses the scenarios in which she has seen the most benefit from brentuximab vedotin (Adcetris) in patients with advanced stage cutaneous T-cell lymphoma (CTCL).

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay